Literature DB >> 19080724

The effects of statins and sitosterols: benefit or not?

Tatu A Miettinen1, Helena Gylling.   

Abstract

Statins reduce plasma plant sterol concentrations and, less consistently, their ratios to cholesterol in short-term studies. They most likely accomplish this by decreasing their transport protein levels. In long-term treatment with large doses of effective statins, serum plant sterol concentrations and frequently their ratios to cholesterol are consistently increased, especially with high, as opposed to low, baseline ratios. Enhanced intestinal absorption, decreased biliary secretion, and reversed cholesterol and plant sterol transport could explain these findings. However, statin treatment increases plant sterol ratios in serum and also in arterial plaques of endarterectomized patients. No trials of functional foods with plant sterols or stanols are available for coronary heart disease, even though their combination with statins effectively reduces low-density lipoprotein cholesterol. Plant sterols increase and plant stanols decrease serum plant sterols. Long-term statin treatment lowers coronary heart disease events only in patients with low baseline plant sterols who have high cholesterol synthesis. No convincing evidence is available that statin-induced phytosterolemia worsens atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19080724     DOI: 10.1007/s11883-009-0004-z

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN: 1523-3804            Impact factor:   5.113


  38 in total

1.  Noncholesterol sterols and cholesterol lowering by long-term simvastatin treatment in coronary patients: relation to basal serum cholestanol.

Authors:  T A Miettinen; T E Strandberg; H Gylling
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-05       Impact factor: 8.311

2.  Serum sterols during stanol ester feeding in a mildly hypercholesterolemic population.

Authors:  H Gylling; P Puska; E Vartiainen; T A Miettinen
Journal:  J Lipid Res       Date:  1999-04       Impact factor: 5.922

3.  Plant sterols in serum and in atherosclerotic plaques of patients undergoing carotid endarterectomy.

Authors:  Tatu A Miettinen; Mikael Railo; Mauri Lepäntalo; Helena Gylling
Journal:  J Am Coll Cardiol       Date:  2005-06-07       Impact factor: 24.094

4.  Effects of plant sterol and stanol ester consumption on lipid metabolism, antioxidant status and markers of oxidative stress, endothelial function and low-grade inflammation in patients on current statin treatment.

Authors:  A De Jong; J Plat; A Bast; R W L Godschalk; S Basu; R P Mensink
Journal:  Eur J Clin Nutr       Date:  2007-05-09       Impact factor: 4.016

5.  By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease?

Authors:  M R Law; N J Wald; S G Thompson
Journal:  BMJ       Date:  1994-02-05

6.  Polymorphism of the hepatic influx transporter organic anion transporting polypeptide 1B1 is associated with increased cholesterol synthesis rate.

Authors:  Marja K Pasanen; Tatu A Miettinen; Helena Gylling; Pertti J Neuvonen; Mikko Niemi
Journal:  Pharmacogenet Genomics       Date:  2008-10       Impact factor: 2.089

7.  Serum cholesterol and cholesterol and lipoprotein metabolism in hypercholesterolaemic NIDDM patients before and during sitostanol ester-margarine treatment.

Authors:  H Gylling; T A Miettinen
Journal:  Diabetologia       Date:  1994-08       Impact factor: 10.122

8.  Lathosterol and other noncholesterol sterols during treatment of hypercholesterolemia with lovastatin alone and with cholestyramine or guar gum.

Authors:  M I Uusitupa; T A Miettinen; P Happonen; T Ebeling; H Turtola; E Voutilainen; K Pyörälä
Journal:  Arterioscler Thromb       Date:  1992-07

9.  Reduction of serum cholesterol with sitostanol-ester margarine in a mildly hypercholesterolemic population.

Authors:  T A Miettinen; P Puska; H Gylling; H Vanhanen; E Vartiainen
Journal:  N Engl J Med       Date:  1995-11-16       Impact factor: 91.245

Review 10.  Sitosterolemia: a gateway to new knowledge about cholesterol metabolism.

Authors:  Knut Erik Berge
Journal:  Ann Med       Date:  2003       Impact factor: 4.709

View more
  3 in total

1.  The role of soluble fiber intake in patients under highly effective lipid-lowering therapy.

Authors:  Silvia C Ramos; Francisco A Fonseca; Soraia H Kasmas; Flávio T Moreira; Tatiana Helfenstein; Ney C Borges; Ronilson A Moreno; Vinicius M Rezende; Fernanda C Silva; Maria C Izar
Journal:  Nutr J       Date:  2011-08-02       Impact factor: 3.271

2.  Differences in synthesis and absorption of cholesterol of two effective lipid-lowering therapies.

Authors:  S H Kasmas; M C Izar; C N França; S C Ramos; F T Moreira; T Helfenstein; R A Moreno; N C Borges; A M Figueiredo-Neto; F A Fonseca
Journal:  Braz J Med Biol Res       Date:  2012-07-19       Impact factor: 2.590

3.  Stigmasterol accumulation causes cardiac injury and promotes mortality.

Authors:  Caroline Tao; Artem A Shkumatov; Shawn T Alexander; Brandon L Ason; Mingyue Zhou
Journal:  Commun Biol       Date:  2019-01-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.